| Cytotoxic activity of compounded anthracycline against rhabdomyosarcoma cancer cell line | | Download |
|
Type: |
|
General Speciality: |
| Homady, M.H. |
Author Name: |
| and Kadhim, H.A. and Abbas Al-Kelaby, K.K. and Aziz, D.Z. and Kadhim, N.J. |
Co Authors Names: |
| Plant Archives |
Publisher Name: |
| Citation (formatted-harvard)
@article{Jawad2018,title = {Cytotoxic activity of compounded anthracycline against rhabdomyosarcoma cancer cell line},journal = {Plant Archives},year = {2018},volume = {18},number = {1},pages = {941-946} |
|
| 2018 |
Publication Year: |
Abstract
Abstract
High selectivity of Cytotoxic Activity of Compounded Anthracycline against Rhabdomyosarcoma Cancer Cell Line that effect of DMT between cancer cell and normal cell line increase the prospects that this compound could serve as leads for novel anticancer drugs and hence may be potential candidates for use in human cancer therapy, however, further investigations will be required in this regard to validate this hypothesis. |
|
